Videos / Weight management and cardiovascular risk reduction: The role of Semaglutide 2.4mg
Weight management and cardiovascular risk reduction: The role of Semaglutide 2.4mg
Description
In this Product Explainer, Dr. Robert Hungerford, GP with a special interest in ASCVD, heart failure and diabetes, explains the role of Semaglutide 2.4mg in weight management and cardiovascular risk reduction in secondary prevention (7 mins).
NEXT LIVE Webcast
:
Days
:
Hours
:
Minutes
Seconds
Prof Jacob George
Fatty Liver, CV Risk, and Post-Menopause
Prof Sebastian King
Paediatric Constipation & Related Issues
Hayley Ryan
Management of Skin Tear in General Practice
Dr Katherine Spira
Migraine vs Chronic Daily Headache
Join us for the next free webcast for GPs and healthcare professionals
High quality lectures delivered by leading independent experts
